Feasibility and effectiveness of Ida Telecare tools for audiology patients

Not Applicable

Completed

• Conditions: Specialty: Ear, nose and throat, Primary sub-specialty: Ear, nose and throat; UKCRC code/ Disease: Ear/ Other disorders of ear; Ear, Nose and Throat; Disorders of ear

• Registration Number: ISRCTN11296341
• Lead Sponsor: ottingham University Hospitals NHS Trust, Research & Innovation

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35195487/ Sub-study 2 qualitative study results (added 22/04/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35436167/ Sub-study 2 randomised clinical trial results (added 22/04/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-01-17
• Study Completion: 2018-08-31
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 57

Inclusion Criteria

1. Adults aged =18 years (no upper age limit)
2. Ability to offer informed consent
3. Fluent in the English language (written and spoken)
4. Access to the Internet

Exclusion Criteria

Previously prescribed hearing aids

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Sub-study 1: Feasibility<br> 1. Usability of the tools are measured using the Think Aloud Techniques in a subset of participants at pre-hearing assessment<br> 2. Patients and audiologists perceptions and experiences of using the telecare tools are examined in a subset of participants using semi-structures interviews at 12 weeks post follow-up assessment<br><br> Sub-study 2, Effectiveness:<br> Self-efficacy is measured using the Measure of Audiological Rehabilitation Self-efficacy for Hearing Aids (MARS-HA) at baseline, post-hearing assessment and 10-12 weeks post-hearing aid fitting.<br>